A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Clinical trial NCT06846554 · RECRUITING

Trial details

NCT number: NCT06846554
Sponsor: Apollo Therapeutics Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2025-04-09
Primary completion: 2027-08-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.